Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Kathryn Anastos, M.D.

Kathryn Anastos, M.D.

Kathryn Anastos, M.D., is the executive co-director for clinical and scientific programs of WE-ACTx (Women's Equity in Access to Care and Treatment), a community-based organization committed to providing HIV primary care, including antiretroviral therapy, to female survivors of genocidal rape in Rwanda. She has also developed and serves as the principal investigator of the Rwandan Women's Cohort Study (RWISA), funded by the U.S. National Institutes of Health (NIH). She is currently a professor of medicine, epidemiology and population health at the Albert Einstein College of Medicine in Bronx, N.Y. Additionally, since 1993, Dr. Anastos has served as the principal investigator for the New York City/Bronx Consortium of the Women's Interagency HIV Study (WIHS), also funded by the NIH.

Disclosures

Dr. Anastos has recently received consulting fees from Merck & Co. and Pfizer, Inc.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 

Tools
 

Advertisement